Assessment of serum cystatin C in children with congenital solitary kidney.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 16572341)

Published in Pediatr Nephrol on March 30, 2006

Authors

Anna Wasilewska1, Walentyna Zoch-Zwierz, Iwona Jadeszko, Tadeusz Porowski, Anna Biernacka, Alicja Niewiarowska, Agata Korzeniecka-Kozerska

Author Affiliations

1: 1st Department of Paediatrics, Medical University of Białystok, ul. Waszyngtona 17, 15-274, Białystok, Poland. annwasil@interia.pl

Articles cited by this

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am (1987) 7.63

Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis (2000) 4.44

20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88

Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int (1995) 2.97

Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. Pediatrics (1998) 2.50

Cystatin C--properties and use as diagnostic marker. Adv Clin Chem (2000) 2.16

Long-term follow-up after partial removal of a solitary kidney. N Engl J Med (1991) 1.99

Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am J Roentgenol (1998) 1.97

Prognosis of patients with unilateral renal agenesis. Pediatr Nephrol (1992) 1.74

Forty-five year follow-up after uninephrectomy. Kidney Int (1993) 1.66

Long-term follow-up of patients who underwent unilateral nephrectomy in childhood. Lancet (1985) 1.55

Renal outcome 25 years after donor nephrectomy. J Urol (2001) 1.47

Sonographic assessment of renal length in normal children. AJR Am J Roentgenol (1984) 1.44

Serum cystatin C--a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol (2005) 1.43

The solitary kidney: a model of chronic hyperfiltration in humans. Am J Kidney Dis (1989) 1.40

Long-term effects of reduced renal mass in humans. Kidney Int (1995) 1.39

Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta (2003) 1.24

Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis (2004) 1.19

Sonographic measurement of absolute and relative renal length in adults. J Clin Ultrasound (1998) 1.16

Occurrence of congenital abnormalities of kidney and urinary tract in 13,775 autopsies. Urology (1991) 1.09

Renal agenesis in British Columbia. Am J Med Genet (1985) 1.08

Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron (2002) 1.06

Congenital renal agenesis: case-control analysis of birth characteristics. Am J Kidney Dis (2002) 1.03

Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int (1983) 1.00

Long-term follow-up of kidney donors: a longitudinal study. Nephrol Dial Transplant (1997) 0.99

Ambulatory blood pressure monitoring in children with a solitary kidney - a comparison between unilateral renal agenesis and uninephrectomy. Blood Press Monit (2001) 0.96

Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron (2002) 0.88

Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol (2002) 0.88

Associated urologic anomalies in children with solitary kidney. J Pediatr Surg (2004) 0.84

[Normal percentiles of kidney size in children as measured by ultrasonography]. Orv Hetil (2001) 0.83

Sonographic standards for a single functioning kidney in children. AJR Am J Roentgenol (1996) 0.81

Is serum cystatin C the marker of choice to predict glomerular filtration rate in paediatric patients? Ann Clin Biochem (2003) 0.81

On the enlargement of the normal congenitally solitary kidney. Br J Urol (1997) 0.81

Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin. Ann Clin Biochem (2003) 0.81

Sonographic assessment of renal length in the first year of life: the problem of "spurious nephromegaly". Pediatr Radiol (2000) 0.79

Follow-up after unilateral nephrectomy in children: is an estimate of glomerular filtration rate necessary? BJU Int (2005) 0.78

Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Clin Transplant (1997) 0.77

[The solitary kidney in children and adolescents. Morphologic and functional characteristics]. Cesk Pediatr (1991) 0.77

High incidence of glomerular sclerosis in rats subjected to uninephrectomy at young age. Nephron (1988) 0.76

Mild proteinuria in patients with unilateral kidney. Klin Wochenschr (1985) 0.75

Compensatory renal hypertrophy after donor nephrectomy. Clin Radiol (1985) 0.75

Sonographic measurements of renal size in normal children and children with compensatory renal hypertrophy. Acta Paediatr Taiwan (1999) 0.75

[Assessment of 24-hour blood pressure function of the single kidney in children with renal agenesis]. Pol Merkur Lekarski (2005) 0.75

Renal dimensions measured by ultrasonography in children: variations as a function of the imaging plane and patient position. Eur Radiol (2004) 0.75

Impact of prenatal screening and diagnosis on the epidemiology of structural congenital anomalies. J Med Screen (1995) 0.75

[Assessment of long-term renal function after nephrectomy. Study of 53 patients]. Med Clin (Barc) (2005) 0.75

Articles by these authors

Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension (2011) 1.79

Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res (2013) 1.61

Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol (2010) 1.45

KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23

Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11

Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. Cancer Res (2010) 1.06

Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res (2010) 1.01

Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res (2012) 1.01

A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92

Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91

MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol (2006) 0.90

Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89

Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C. Cancer Res (2010) 0.89

Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86

Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86

Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. Cancer Res (2013) 0.85

[Assessment of oxalate concentration in serum and urine of children with renal stones]. Wiad Lek (2005) 0.84

Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol (2010) 0.81

Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81

Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81

Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.80

A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol (2011) 0.80

Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol (2006) 0.79

Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79

Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr (2006) 0.78

Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78

Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78

A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78

Glutathione reductase activity correlates with concentration of extracellular matrix degradation products in synovial fluid from patients with joint diseases. Acta Biochim Pol (2009) 0.77

[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77

[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski (2009) 0.77

Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele. Scand J Urol (2013) 0.77

Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol (2004) 0.76

Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76

[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76

Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76

High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol (2006) 0.75

Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab (2005) 0.75

Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol (2005) 0.75

Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75

Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis Markers (2013) 0.75

[The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Pol Merkur Lekarski (2005) 0.75

[The concentration of plasma anion oxalate in children treatment antibiotics beta lactame]. Pol Merkur Lekarski (2006) 0.75

Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr (2006) 0.75

Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75

[Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment]. Pol Merkur Lekarski (2003) 0.75

[Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek (2009) 0.75

Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr (2006) 0.75

[Assessment of fructose-1,6-biphosphatase in urine of children with acute pyelonephritis]. Pol Merkur Lekarski (2004) 0.75

[Serum cystatin C concentration in children with urinary stones]. Pol Merkur Lekarski (2006) 0.75

[Reference values of 24-hour ambulatory blood pressure in healthy children by height]. Pol Merkur Lekarski (2004) 0.75

[Urolithiasis risk factors in obese and overweight children]. Pediatr Endocrinol Diabetes Metab (2012) 0.75

[The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. Pol Merkur Lekarski (2008) 0.75

[Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski (2009) 0.75

High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75

Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele. Urol Int (2015) 0.75

[Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski (2008) 0.75

[Reference values of arterial pressure depending on age, assessed by 24-hour ambulatory monitoring]. Pol Merkur Lekarski (2003) 0.75

[Assessment of 24-hour blood pressure function of the single kidney in children with renal agenesis]. Pol Merkur Lekarski (2005) 0.75

[Vasculitis of cerebral vessels, probable cause of neurological complications in a child with Schonlein-Henoch purpura]. Pol Merkur Lekarski (2002) 0.75

[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski (2010) 0.75

[Urinary TGF-beta1 excretion in children with renal cysts]. Przegl Lek (2006) 0.75

[Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski (2008) 0.75

[Metabolic acidosis in children with newly diagnosed type 1 diabetes and risk factors of urolithiasis]. Pediatr Endocrinol Diabetes Metab (2012) 0.75

Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol (2007) 0.75